EUnetHTA Joint Action 3 is the scientific and technical component of EU cooperation on HTA. EUnetHTA 3 builds on years of long standing collaboration between HTA agencies, financially supported by the EU since early 2000. The current Joint Action (2016 – 2021) is co-funded by the EU Health Programme and includes government appointed organisations and a large number of relevant regional agencies and not-for-profit organisations that produce or contribute to HTA in Europe (i.e. 86 organisations from 26 Member States plus Norway, Serbia, Switzerland, Ukraine and United Kingdom).
Responding to the needs of policy makers and public health authorities for researched, timely and reliable information, EUnetHTA has launched its Covid-19-related repository of publications and outputs. The repository gathers publications by EUnetHTA and by HTA organisations on testing methods and devices, but also on treatment options, and other public health measures relevant to Covid-19.
The repository of HTA publications on testing methods and devices for SARS-COV-2 also responds to one of the follow-up actions to the Commission Communication on “Guidelines on Covid-19 in vitro diagnostic tests and their performance”.